Archive - May 2021
Sanofi, GSK’s COVID-19 vaccine achieves positive Phase II results
Positive results for GSK/CureVac’s COVID-19 vaccine
NICE recommends Keytruda for colorectal cancer patients with rare mutations
New trial data for Keytruda in triple-negative breast cancer
PharmaTimes are proud to confirm the launch of the 2021 Sales Awards
Remove barriers restricting the research of controlled drugs, says RPS
Alzheimer’s drug designed using Exscientia’s AI technology enters clinic
NICE nod for BMS’ Opdivo in advanced oesophageal cancer